NCT03003429

Brief Summary

The heart rate variability (HRV) is a measure of the autonomic nervous system (ANS). In the model of anorexia nervosa, ANS is disturbed with mostly a predominance of activation of the parasympathetic nervous system and a decrease of the sympathetic system. Various explanations of this these dysfunctions are proposed in literature, mainly malnutrition, physical hyperactivity, anxiety, that are known characteristics of anorexia nervosa. The primary aim of this study is to evaluate correlation between ANS dysfunction and anxiety in anorexia nervosa. Other objectives of this study are firstly to evaluate correlation between ANS dysfunction and others parameters (weight, body mass index, depression, physical activity, purgative ou restrictive type, duration of disease, smoking) in anorexia nervosa and secondly to see if HRV is a predictive parameter of the evolution of anorexia nervosa.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 22, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 28, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 12, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 12, 2018

Completed
Last Updated

December 12, 2019

Status Verified

December 1, 2019

Enrollment Period

1.5 years

First QC Date

December 22, 2016

Last Update Submit

December 11, 2019

Conditions

Keywords

Heart rate variabilityanxietyAutonomic dysfunction

Outcome Measures

Primary Outcomes (1)

  • Statistical correlation between autonomic dysfunction (measured by HRV) and anxiety (measured by questionnaire)

    The composite measure consists of the following :- Time and spectral-domain measures of HRV measured by nocturn registration with heart rate monitor and polar RS800CX Time domain - NN (normal-to-normal R-R interval), HRV index (total number of all NN/ the height of the histogram of all NN), SDNN (standard deviation of the NN), RMSSD (the root mean square of differences of successive NN), NN50 (Number of pairs of adjacent NN intervals differing by more than 50 ms in the entire recording) and pNN50 (NN50/total number of all NN), SDANN (Standard deviation of the average of NN intervals in all 5-minute segments of a long recording), SDNNIDX (Mean of the standard deviation in all 5-minute segments of a long recording) Frequency domain - VLF Power (very low frequency; \<0.04 Hz), LF Power (low frequency; 0.04\~0.15 Hz), HF Power (high frequency; 0.15\~0.4 Hz), LF/HF ratio value \- State-Trait Anxiety Inventory: version Y (STAI- form Y) - Morning blood cortisol level and serum prealbumin lev

    at day 0

Secondary Outcomes (4)

  • Statistical correlation between autonomic dysfunction (measured by HRV) and measures of Beck Depression inventory

    at day 0

  • Statistical correlation between autonomic dysfunction (measured by HRV) and measures of Beck Depression inventory

    at 6 months

  • Statistical correlation between autonomic dysfunction (measured by HRV) and measures of International physical activity questionnaire

    at 6 months

  • Statistical correlation between autonomic dysfunction (measured by HRV) and measures of International physical activity questionnaire

    at day 0

Study Arms (1)

Heart rate monitor

EXPERIMENTAL

The intervention consist in monitoring the heart rate variability during one night by using a heart rate monitor and a Polar RS800CX

Other: Heart rate monitor

Interventions

The intervention consist in monitoring the heart rate variability during one night by using a heart rate monitor and a Polar RS800CX

Heart rate monitor

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women
  • Aged from 18 to 65 years
  • Criteria of anorexia nervosa (DSM V)
  • Body mass index (BMI) \< 18 kg/m2
  • Written consent to participate in the study
  • Patient affiliated to a social security system

You may not qualify if:

  • Pacemaker or other implantable electronic device
  • Current comorbidity psychiatric disorder according to Axis I of DSM IV : severe depression (BDI \> 8/13), substance use disorder .
  • Psychotropic drugs or ongoing steroid therapy ;
  • Pregnancy or breast-feeding ;
  • History or known cardiovascular disorder, including hypertension ( \> 140/90 mmHg ) , heart failure, arrhythmia and conduction disorder .
  • Major protected by a legal protection
  • Minors

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon

Bron, 69500, France

Location

MeSH Terms

Conditions

Anorexia NervosaAnxiety DisordersPrimary Dysautonomias

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental DisordersAutonomic Nervous System DiseasesNervous System Diseases

Study Officials

  • Sylvain ICETA, MD

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2016

First Posted

December 28, 2016

Study Start

March 1, 2017

Primary Completion

September 12, 2018

Study Completion

September 12, 2018

Last Updated

December 12, 2019

Record last verified: 2019-12

Locations